Social Cognition, Memory, and Executive Functions in Bipolar Disorder and Major Depressive Disorder

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorCHU de Reims

About this trial

Bipolar disorder (BD) are common psychiatric disorders often misdiagnosed, leading to delayed treatment. Even during stable phases, individuals with bipolar disorder experience residual cognitive impairments that affect their social functioning and quality of life.

This study aims to explore social cognition deficits (e.g., emotional processing, theory of mind, attribution bias) and their relationship with executive functions (e.g., flexibility, inhibition, working memory) and memory in bipolar disorder and major depressive disorder, ultimately seeking to improve understanding of their functional outcomes.

Social cognition and executive functions in BD are both state- and trait-related. One recent meta-analysis demonstrated impairment in social cognitive domains for manic, depressive, and euthymic bipolar disorders' patients but it remains unclear whether these social cognitive deficits in BD are due to executive functions and/or other confounding effects.

Few studies have investigated the interdependency between these cognitive impairments in these two affective disorders while a better understanding of the link between executive functions and social cognition seems crucial in order to better characterize the nature of patients' deficits and thus their caring.

Eligibility criteria

Qualifiers

Patients between 18 and 65 years old, men or women

Having a diagnosis of bipolar disorder or depressive disorder

No substantial change in treatment for 2 weeks preceding study enrollment

Being a native French speaker

Disqualifiers

The presence of any alcohol use disorder or any other substance use disorder in the last six months, except for tobacco dependence

A significant general medical illness, including neurological disorders or head trauma

A sensorial impairment uncorrected (visual and/or hearing)

Participants between 18 and 65 years old, men or women

Trial design

Treatments tested in this trial

  • Analysis of social cognition, memory functioning, and executive functioning processes

Treatment groups

180 Participants
are divided into 6 treatment groups

6

Treatment groups

See each treatment group below.

Sponsors and collaborators

CHU de Reims

Lead sponsor

EPSM de la Marne

Collaborator